Azilsartan Medoxomil

2 trials CCardiology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

11 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Oversight events:

9 temporary halts 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Focal segmental glomerulosclerosis 1

Sponsors using this IMP

Dimerix Bioscience Pty Limited 1 Novartis Pharma AG 1

All trials

2 total

Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended

2023-504597-37-00 Phase III 7 countries Dimerix Bioscience Pty Limited
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Phase II 11 countries Novartis Pharma AG

Showing 1–2 of 2 trials

← All drugs A–Z